| Product Name | MF | CAS | Details |
|---|
| HIF-2α-IN-9 | C12H13F5O4S2 | 2648334-36-3 | Details |
| NNRTIs-IN-1 | C28H22N6O3 | 2925364-09-4 | Details |
| Antimalarial agent 26 | C20H22N4O3 | 2299199-56-5 | Details |
| HIV-1 protease-IN-8 | C25H35N3O5S | 2925287-55-2 | Details |
| ATR-IN-23 | C20H22N6O3S2 | 2923800-62-6 | Details |
| Antimalarial agent 24 | C20H16N4O2 | 2299199-54-3 | Details |
| TRK-IN-23 | C20H17FN4O2 | 2924344-29-4 | Details |
| HDAC ligand-1 | C7H8N2O | 34840-28-3 | Details |
| RIP1 kinase inhibitor 5 | C13H17F2NO2 | 2428422-17-5 | Details |
| Antileishmanial agent-16 | C27H37N5O4 | 2934738-41-5 | Details |
| RIP1 kinase inhibitor 4 | 2919836-00-1 | Details |
| Antileishmanial agent-17 | C27H37N5O5 | 2934738-40-4 | Details |
| PB131 | C16H16FN3O2 | 2924425-63-6 | Details |
| Antileishmanial agent-15 | C28H39N5O4 | 2934738-38-0 | Details |
| Enpp-1-IN-17 | C18H24N4O2 | 2289736-54-3 | Details |
| Mcl-1 inhibitor 13 | 2445466-06-6 | Details |
| SLMP53-2 | C26H22N2O2 | 1826116-38-4 | Details |
| Antibacterial agent 141 | C23H27ClN2O3 | 2930013-56-0 | Details |
| HIV-1 inhibitor-56 | C22H14ClN7O2S | 2952530-45-7 | Details |
| Lp-PLA2-IN-16 | C22H17F5N4O3 | 1865780-73-9 | Details |
| AMPA receptor modulator-4 | C11H12ClFN2O2S | 2917551-59-6 | Details |
| Lp-PLA2-IN-12 | 2637485-14-2 | Details |
| RIP1 kinase inhibitor 7 | C20H20FN3O | 2428401-23-2 | Details |
| ALK2-IN-5 | C24H32N8O2 | 2414149-20-3 | Details |
| MDM2/XIAP-IN-2 | C29H32N2O4S | 2761969-85-9 | Details |
| Tau protein aggregation-IN-1 | C17H11BrN2O2 | 916179-45-8 | Details |
| RIP1 kinase inhibitor 6 | C19H18F2N2O3 | 2428401-62-9 | Details |
| TNF-α-IN-10 | C17H14O4 | 2247720-56-3 | Details |
| MEK-IN-6 | C18H20FN3O4S | 2845151-86-0 | Details |
| A1/A3 AR antagonist 3 | C22H19N5O3 | 2665804-57-7 | Details |
| STAT6-IN-3 | C32H35IN3O7P | 371919-80-1 | Details |
| MEK-IN-6 hydrate | 2845153-35-5 | Details |
| FKBP51F67V-selective antagonist Ligand2 | C43H56N2O10 | 1680228-76-5 | Details |
| Lp-PLA2-IN-15 | C22H17F5N4O3 | 1865796-11-7 | Details |
| SB-649701 | C27H28N4O3 | 935262-95-6 | Details |
| SORT-PGRN interaction inhibitor 3 | C15H19Cl2NO3 | 2691846-87-2 | Details |
| Bromodomain inhibitor-12 (edisylate) | C28H38N4O5.C2H6O6S2 | 2010124-27-1 | Details |
| Lp-PLA2-IN-14 | 2756855-66-8 | Details |
| Bivamelagon hydrochloride | C35H54Cl2N4O4 | 2641595-55-1 | Details |
| Tegeprotafib | C13H11FN2O5S | 2407610-46-0 | Details |
| VMAT2-IN-2 tosylate | C27H36F3NO6S | 2608770-12-1 | Details |
| IRE1α kinase-IN-9 | C24H24N2O6 | 1338933-30-4 | Details |
| SHP2-IN-14 | C22H20Cl2N8O | 2673400-91-2 | Details |
| IPG7236 | C23H31N3O3S | 2756350-91-9 | Details |
| PCSK9-IN-17 | C16H19N5OS | 2455424-72-1 | Details |
| PCSK9-IN-16 | C16H20N6O2S3 | 2455424-51-6 | Details |
| ATR-IN-24 | C23H26N6O2 | 2370889-43-1 | Details |
| TLR7/8 agonist 8 | C24H30N6O | 2649170-16-9 | Details |
| DRI-C21041 | C30H21N3O7S | 2101765-78-8 | Details |
| Bivamelagon | C35H53ClN4O4 | 2641595-54-0 | Details |
| ROCK-IN-6 | C19H19N5O8S | 2489328-74-5 | Details |
| THRβ receptor agonist-1 | 2403721-00-4 | Details |
| P2X3 antagonist 38 | C22H25F3N6O3 | 2545974-71-6 | Details |
| PI3Kγ inhibitor 7 | C31H25N9O2 | 2575863-25-9 | Details |
| CXCR4-IN-1 | C23H32N6 | 2304750-48-7 | Details |
| TLR7/8 agonist 9 | C20H26N6O | 2649170-17-0 | Details |
| SOS1-IN-16 | C30H31F3N4O3 | 2930763-85-0 | Details |
| Bromodomain inhibitor-12 | 2010124-06-6 | Details |
| Lp-PLA2-IN-13 | C22H17F5N4O4 | 2756855-62-4 | Details |
| HPK1 antagonist-1 | C28H29FN6O2 | 2628489-56-3 | Details |
| IRE1α kinase-IN-8 | 1338933-29-1 | Details |
| Antifungal agent 59 | 2422019-96-1 | Details |
| SUCNR1-IN-1 | C26H22ClF3N2O4 | 2711753-52-3 | Details |
| DSO-5a | C23H24N2O7 | 2195411-63-1 | Details |
| SOS1/KRAS-IN-1 | C24H26F3N5O | 2836330-34-6 | Details |
| BDM91514 | 2892824-90-5 | Details |
| SARS-CoV-2-IN-57 | C23H37N3O | 1265624-68-7 | Details |
| UPCDC30766 | C30H32F2N6O3S | 2152623-68-0 | Details |
| MmpL3-IN-2 | C27H30N2 | 2944458-65-3 | Details |
| TLR8 agonist 6 | C19H29N7O2 | 2616605-55-9 | Details |
| URAT1&XO inhibitor 2 | C14H12BrNO3 | 1239488-96-0 | Details |
| BBDDL2059 | C27H36N4O4S | 2691174-27-1 | Details |
| JAK-IN-30 | C19H26N8S | 2891469-99-9 | Details |
| Z1078601926 | C14H19FN2O | 1493256-85-1 | Details |
| KAT modulator-1 | C20H36O2 | 1314006-43-3 | Details |
| Antiproliferative agent-32 | C19H15NO2 | 2925814-05-5 | Details |
| PROTAC α-synuclein degrader 5 | C39H41N7O10 | 2781922-42-5 | Details |
| K-80001 | C20H17FO2 | 242800-40-4 | Details |
| AMPK activator 11 | C25H20N4O2 | 2948304-00-3 | Details |
| FGFR-IN-11 | C28H29ClN4O4 | 2658488-68-5 | Details |
| Antiproliferative agent-30 | C24H26N4O4 | 2713553-88-7 | Details |
| CDK7-IN-22 | C22H25F3N6 | 2173190-60-6 | Details |
| PIKfyve-IN-2 | C22H22N8O | 2245319-25-7 | Details |
| PHD2-IN-1 | C21H23ClN4O5 | 2768219-28-7 | Details |
| SSI-4 | C19H21ClN4O3 | 1875084-68-6 | Details |
| RET-IN-23 | C28H28FN11 | 2479961-46-9 | Details |
| Mosnodenvir | C26H22ClF3N2O6S | 2890688-86-3 | Details |
| URAT1&XO inhibitor 1 | C20H13N5O3S | 2669726-78-5 | Details |
| ETAP | C18H17N3O | 2575731-47-2 | Details |
| S-Gem | C13H15F2N3O6S2 | 2169925-98-6 | Details |
| DGKζ-IN-1 | C27H25F3N6O2S | 2660218-70-0 | Details |
| DRI-C25441 | C31H21N3O6 | 2101765-83-5 | Details |
| JAK-IN-28 | C20H18ClN7O | 2445500-22-9 | Details |
| Tubulin polymerization-IN-42 | C22H21NO5 | 2640220-51-3 | Details |
| BChE-IN-17 | C23H23BrN2O4S2 | 2425632-57-9 | Details |
| Protein kinase inhibitor 5 | C29H31F2N7O | 2278204-94-5 | Details |
| Antitumor agent-101 | C26H38N6O3 | 2848632-52-8 | Details |
| PAD4-IN-2 | C20H23BClN7O6 | 2642327-52-2 | Details |
| MAT2A-IN-12 | C20H17NO3 | 631897-75-1 | Details |
| IRAK4-IN-28 | C27H31N9O3 | 2952532-92-0 | Details |
| Product Total： Product Page： | ||||
| 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 | ||||